Paying users zone. Data is covered by hidden.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

Microsoft Excel LibreOffice Calc

Allergan PLC (AGN)


Long-term Debt and Solvency Analysis

Difficulty: Beginner


Ratios (Summary)

Allergan PLC, debt and solvency ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Debt Ratios
Debt to equity hidden hidden hidden hidden hidden
Debt to capital hidden hidden hidden hidden hidden
Debt to assets hidden hidden hidden hidden hidden
Financial leverage hidden hidden hidden hidden hidden
Coverage Ratios
Interest coverage hidden hidden hidden hidden hidden
Fixed charge coverage hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

Ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. Allergan PLC’s debt to equity ratio improved from 2016 to 2017 and from 2017 to 2018.
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Allergan PLC’s debt to capital ratio improved from 2016 to 2017 and from 2017 to 2018.
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. Allergan PLC’s debt to assets ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. Allergan PLC’s financial leverage ratio improved from 2016 to 2017 and from 2017 to 2018.

Ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Allergan PLC’s interest coverage ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.
Fixed charge coverage ratio A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. Allergan PLC’s fixed charge coverage ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.

Debt to Equity

Allergan PLC, debt to equity calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Current portion of long-term debt and capital leases hidden hidden hidden hidden hidden
Long-term debt and capital leases, excluding current portion hidden hidden hidden hidden hidden
Total debt hidden hidden hidden hidden hidden
 
Shareholders’ equity hidden hidden hidden hidden hidden
Ratio
Debt to equity1 hidden hidden hidden hidden hidden
Benchmarks
Debt to Equity, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Debt to Equity, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Debt to Equity, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

1 2018 Calculation
Debt to equity = Total debt ÷ Shareholders’ equity
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. Allergan PLC’s debt to equity ratio improved from 2016 to 2017 and from 2017 to 2018.

Debt to Capital

Allergan PLC, debt to capital calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Current portion of long-term debt and capital leases hidden hidden hidden hidden hidden
Long-term debt and capital leases, excluding current portion hidden hidden hidden hidden hidden
Total debt hidden hidden hidden hidden hidden
Shareholders’ equity hidden hidden hidden hidden hidden
Total capital hidden hidden hidden hidden hidden
Ratio
Debt to capital1 hidden hidden hidden hidden hidden
Benchmarks
Debt to Capital, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Debt to Capital, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Debt to Capital, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

1 2018 Calculation
Debt to capital = Total debt ÷ Total capital
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Allergan PLC’s debt to capital ratio improved from 2016 to 2017 and from 2017 to 2018.

Debt to Assets

Allergan PLC, debt to assets calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Current portion of long-term debt and capital leases hidden hidden hidden hidden hidden
Long-term debt and capital leases, excluding current portion hidden hidden hidden hidden hidden
Total debt hidden hidden hidden hidden hidden
 
Total assets hidden hidden hidden hidden hidden
Ratio
Debt to assets1 hidden hidden hidden hidden hidden
Benchmarks
Debt to Assets, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Debt to Assets, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Debt to Assets, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

1 2018 Calculation
Debt to assets = Total debt ÷ Total assets
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. Allergan PLC’s debt to assets ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.

Financial Leverage

Allergan PLC, financial leverage calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Total assets hidden hidden hidden hidden hidden
Shareholders’ equity hidden hidden hidden hidden hidden
Ratio
Financial leverage1 hidden hidden hidden hidden hidden
Benchmarks
Financial Leverage, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Financial Leverage, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Financial Leverage, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

1 2018 Calculation
Financial leverage = Total assets ÷ Shareholders’ equity
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. Allergan PLC’s financial leverage ratio improved from 2016 to 2017 and from 2017 to 2018.

Interest Coverage

Allergan PLC, interest coverage calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Net income (loss) attributable to shareholders hidden hidden hidden hidden hidden
Add: Net income attributable to noncontrolling interest hidden hidden hidden hidden hidden
Less: Income (loss) from discontinued operations, net of tax hidden hidden hidden hidden hidden
Add: Income tax expense hidden hidden hidden hidden hidden
Add: Interest expense hidden hidden hidden hidden hidden
Earnings before interest and tax (EBIT) hidden hidden hidden hidden hidden
Ratio
Interest coverage1 hidden hidden hidden hidden hidden
Benchmarks
Interest Coverage, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Interest Coverage, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Interest Coverage, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

1 2018 Calculation
Interest coverage = EBIT ÷ Interest expense
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Allergan PLC’s interest coverage ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.

Fixed Charge Coverage

Allergan PLC, fixed charge coverage calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Statutory tax rate hidden hidden hidden hidden hidden
Selected Financial Data (USD $ in thousands)
Net income (loss) attributable to shareholders hidden hidden hidden hidden hidden
Add: Net income attributable to noncontrolling interest hidden hidden hidden hidden hidden
Less: Income (loss) from discontinued operations, net of tax hidden hidden hidden hidden hidden
Add: Income tax expense hidden hidden hidden hidden hidden
Add: Interest expense hidden hidden hidden hidden hidden
Earnings before interest and tax (EBIT) hidden hidden hidden hidden hidden
Add: Property rental expense for operating leases hidden hidden hidden hidden hidden
Earnings before fixed charges and tax hidden hidden hidden hidden hidden
 
Interest expense hidden hidden hidden hidden hidden
Property rental expense for operating leases hidden hidden hidden hidden hidden
Dividends on preferred shares hidden hidden hidden hidden hidden
Dividends on preferred shares, tax adjustment1 hidden hidden hidden hidden hidden
Dividends on preferred shares, after tax adjustment hidden hidden hidden hidden hidden
Fixed charges hidden hidden hidden hidden hidden
Ratio
Fixed charge coverage2 hidden hidden hidden hidden hidden
Benchmarks
Fixed Charge Coverage, Competitors3
AbbVie Inc. hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Fixed Charge Coverage, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Fixed Charge Coverage, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).

1 2018 Calculation
Dividends on preferred shares, tax adjustment = (Dividends on preferred shares × Statutory tax rate) ÷ (1 − Statutory tax rate)
= (hidden × hidden) ÷ (1 − hidden) = hidden

2 2018 Calculation
Fixed charge coverage = Earnings before fixed charges and tax ÷ Fixed charges
= hidden ÷ hidden = hidden

3 Click competitor name to see calculations.

Ratio Description The company
Fixed charge coverage ratio A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. Allergan PLC’s fixed charge coverage ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.